The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sch 1 Update - Duke Royalty Limited

22 Mar 2017 15:45

RNS Number : 2396A
AIM
22 March 2017
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Duke Royalty Limited (the "Company" or "Duke")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

 

4th Floor, West Wing

St Peter Port

Guernsey

GY1 2JA

 

COUNTRY OF INCORPORATION:

 

Guernsey

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

www.dukeroyalty.com/

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Duke was incorporated as Praetorian Resources Limited in 2012 and established as a natural resource investment vehicle. On 16 June 2015, Shareholders resolved to amend the Company's investing policy to invest in a diversified portfolio of royalty finance and related opportunities and to change its name to Duke Royalty Limited. On 29 March 2016, the Company announced the sale of the last of its natural resource investments and is now seeking re-admission to AIM as a Rule 8 investing company to enable it to implement its investing policy, which is detailed below:

 

To build a stable and reliable income for Shareholders by seeking to invest in, without limitation and restrictions (including geographic restrictions):

 

(i) long-term, revenue-based royalties in private and/or public companies; and/or

(ii) other alternative asset classes and/or financing instruments from time to time that bear similar risk and return characteristics to the investments in paragraph (i).

 

 

The Company has built a near-term pipeline of potential Royalty Financing transactions

amounting to approximately £75 million. Duke will provide financing to Royalty Partners in one or more instalments in return for monthly royalty payments.

 

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Number of Ordinary Shares of no par value to be admitted: 45,377,459

 

The shares are freely transferable and have no restrictions placed on them.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Capital raised on admission: £15.0 million

 

Market capitalisation on admission: £18.2 million

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

Percentage of AIM securities not in public hands at admission: 29%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

The Company is not listed on any other exchange.

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Nigel Norman Birrell (Non-Executive Chairman)

Neil Allan Johnson (Chief Executive Officer)

Charles (Charlie) Cannon-Brookes (Executive Director)

James (Jim) Alan Ryan (Non-Executive Director)

Mark Wilson Le Tissier (Non-Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Shareholder Name

Percentage Holding before Admission

Percentage Holding after Admission

Neil Johnson (1)

11.55%

3.66%

Artemis Investment Management plc

5.78%

3.76%

Charlie Cannon-Brookes (2)

5.76%

6.10%

Jim Ryan

5.08%

1.43%

Nigel Birrell

5.08%

1.16%

Richard Lockwood (3)

4.87%

2.72%

Justin Cochrane

4.00%

1.52%

APAC Resources Limited

3.31%

0.57%

Malcolm Burne

3.30%

0.85%

Ravenscroft Ltd

3.17%

2.58%

Hargreave Hale Limited

0%

16.53%

Partner Value Investments Inc

0%

9.64%

AXA Investment Managers

0%

8.26%

Walker Crips Group plc

0%

4.41%

Henderson Global Investors Limited

0%

3.31%

 

(1) Of this percentage holding, 6.35 per cent. before Admission and 1.10 per cent. after Admission is legally owned by Abingdon Capital Corporation. Neil Johnson is Abingdon's sole voting shareholder.

(2) Of this percentage holding, 3.74 per cent. before Admission and 2.99 per cent. after Admission is legally owned by Arlington Group Asset Management Limited ("Arlington"). Charlie Cannon-Brookes is the investment director of Arlington and holds 40 per cent. of the voting shares of Arlington.

(3) Richard Lockwood is a director of Arlington and holds 20 per cent. of the voting shares of Arlington.

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

 

WH Ireland Group plc

Ravenscroft Limited

CED Capital Limited

2428555 Ontario Inc

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 March

(ii) No historical financial information is being included in the AIM admission document. The date of the last notified accounts of the Company was 30 September 2016

(iii) audited results for the year to 31 March 2017 by 30 September 2017;

unaudited interim results for the six months to 30 September 2017 by 31 December 2017;

audited results for the year to 31 March 2018 by 30 September 2018

 

EXPECTED ADMISSION DATE:

 

23 March 2017

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Grant Thornton UK LLP

30 Finsbury Square

London

EC2P 2YU

 

NAME AND ADDRESS OF BROKER:

 

Cantor Fitzgerald Europe

One Churchill Place

London

E14 5RB

 

Mirabaud Securities LLP

33 Grosvenor Place

London

SW1X 7HY

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

The Admission Document, containing full details about Duke Royalty Limited and the admission of its issued share capital to trading on AIM, will be available during normal business hours on any weekday (excluding Saturdays, Sundays and public holidays) at the registered office of McCarthy Tétrault, 26th Floor, 125 Old Broad Street, London, EC2N 1AR and the registered office of the Company until at least one month after Admission.

 

Copies of the Admission Document will also be available on the Company's website at www.dukeroyalty.com following Admission.

 

DATE OF NOTIFICATION:

22 March 2017

 

NEW/ UPDATE:

 

UPDATE

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIMPGUUCWUPMGAP
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.